Page contentsPage contents Shortage information Key facts Key dates Related medicine information Shortage information The shortage affecting Hycamtin has been resolved and the information and recommendations which were issued during the shortage no longer apply. Key facts Medicines affected Hycamtin Supply shortage status Resolved International non-proprietary name (INN) or common name topotecan Therapeutic area (MESH) Ovarian NeoplasmsUterine Cervical NeoplasmsSmall Cell Lung Carcinoma Pharmaceutical forms affected Capsule, hard Strengths affected 0.5 mg1 mg Availability of alternatives Yes Key dates First published 07/11/2023 Last updated 24/04/2026 Related medicine information Hycamtin Information on shortages and national shortage registers Medicine Shortages Single Point of Contact (SPOC) Working Party National competent authorities (human) Eligible healthcare professionals' organisations Eligible patients and consumers' organisations Share this page